SK282303B6 - Spôsob výroby liekovej formy obsahujúcej karbamazepín s oneskoreným uvoľňovaním účinnej látky - Google Patents

Spôsob výroby liekovej formy obsahujúcej karbamazepín s oneskoreným uvoľňovaním účinnej látky Download PDF

Info

Publication number
SK282303B6
SK282303B6 SK1646-96A SK164696A SK282303B6 SK 282303 B6 SK282303 B6 SK 282303B6 SK 164696 A SK164696 A SK 164696A SK 282303 B6 SK282303 B6 SK 282303B6
Authority
SK
Slovakia
Prior art keywords
carbamazepine
film
ratio
eudragit
active substance
Prior art date
Application number
SK1646-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK164696A3 (en
Inventor
Karl-Friedrich Landgraf
Sabine Reiss
Eberhard Schubert
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of SK164696A3 publication Critical patent/SK164696A3/sk
Publication of SK282303B6 publication Critical patent/SK282303B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
SK1646-96A 1994-07-01 1995-06-22 Spôsob výroby liekovej formy obsahujúcej karbamazepín s oneskoreným uvoľňovaním účinnej látky SK282303B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944423078 DE4423078B4 (de) 1994-07-01 1994-07-01 Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
PCT/DE1995/000805 WO1996001112A1 (de) 1994-07-01 1995-06-22 Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung

Publications (2)

Publication Number Publication Date
SK164696A3 SK164696A3 (en) 1997-06-04
SK282303B6 true SK282303B6 (sk) 2002-01-07

Family

ID=6522000

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1646-96A SK282303B6 (sk) 1994-07-01 1995-06-22 Spôsob výroby liekovej formy obsahujúcej karbamazepín s oneskoreným uvoľňovaním účinnej látky

Country Status (23)

Country Link
US (1) US5888545A (et)
EP (1) EP0768882B1 (et)
JP (1) JPH10502358A (et)
KR (1) KR100344477B1 (et)
CN (1) CN1101191C (et)
AT (1) ATE169818T1 (et)
BG (1) BG62794B1 (et)
BR (1) BR9508202A (et)
CA (1) CA2194216A1 (et)
CZ (1) CZ288028B6 (et)
DE (2) DE4423078B4 (et)
DK (1) DK0768882T3 (et)
EE (1) EE03954B1 (et)
ES (1) ES2122630T3 (et)
GE (1) GEP19991819B (et)
HU (1) HU221486B (et)
LT (1) LT4251B (et)
LV (1) LV11820B (et)
PL (1) PL180979B1 (et)
RU (1) RU2141825C1 (et)
SK (1) SK282303B6 (et)
UA (1) UA32598C2 (et)
WO (1) WO1996001112A1 (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162466A (en) * 1999-04-15 2000-12-19 Taro Pharmaceutical Industries Ltd. Sustained release formulation of carbamazepine
US20060275367A1 (en) * 2005-04-25 2006-12-07 Shubha Chungi Extended release formulations
WO2007048219A2 (en) * 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
FR2940910A1 (fr) * 2009-01-09 2010-07-16 Vetoquinol Sa Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) * 2016-07-19 2016-10-12 南京正宽医药科技有限公司 一种卡马西平片及其制备方法
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

Also Published As

Publication number Publication date
DK0768882T3 (da) 1999-05-25
US5888545A (en) 1999-03-30
KR970703774A (ko) 1997-08-09
LV11820B (en) 1997-12-20
BG101080A (en) 1997-08-29
GEP19991819B (en) 1999-11-05
LT4251B (en) 1997-12-29
CN1101191C (zh) 2003-02-12
WO1996001112A1 (de) 1996-01-18
PL317996A1 (en) 1997-05-12
DE4423078B4 (de) 2005-01-13
UA32598C2 (uk) 2001-02-15
DE4423078A1 (de) 1996-01-04
ES2122630T3 (es) 1998-12-16
PL180979B1 (pl) 2001-05-31
CN1153475A (zh) 1997-07-02
KR100344477B1 (ko) 2002-11-23
BG62794B1 (bg) 2000-08-31
EE03954B1 (et) 2003-02-17
EP0768882B1 (de) 1998-08-19
DE59503283D1 (de) 1998-09-24
EP0768882A1 (de) 1997-04-23
CA2194216A1 (en) 1996-01-18
BR9508202A (pt) 1997-11-11
LT97012A (en) 1997-08-25
EE9600202A (et) 1997-06-16
ATE169818T1 (de) 1998-09-15
HUT76821A (en) 1997-11-28
CZ288028B6 (cs) 2001-04-11
JPH10502358A (ja) 1998-03-03
LV11820A (lv) 1997-08-20
HU221486B (en) 2002-10-28
SK164696A3 (en) 1997-06-04
CZ382696A3 (en) 1997-05-14
HU9603565D0 (en) 1997-02-28
RU2141825C1 (ru) 1999-11-27

Similar Documents

Publication Publication Date Title
EP0527637B1 (en) Spheroids containing dittiazem and a spheronizing agent
ES2260042T3 (es) Formas farmaceuticas de administracion oral que contienen tramadol de liberacion retardada.
US4666703A (en) Storage-stable, quick-disintegrating pressed shapes containing pharmaceutical active substances
US6576260B2 (en) Sustained-release form of administration containing tramadol saccharinate
DE3625458A1 (de) Granulaere form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
DE19927689A1 (de) Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US6951657B1 (en) Particles coated with granulated crystalline ibuprofen
US20060039997A1 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
EP1653932A1 (en) Modified release compositions for minocycline
SK278868B6 (sk) Prípravok s retardovaným uvoľňovaním účinnej látky
SK282303B6 (sk) Spôsob výroby liekovej formy obsahujúcej karbamazepín s oneskoreným uvoľňovaním účinnej látky
US20090074867A1 (en) Orally dispersible pharmaceutical composition and process for the preparation thereof
US5897877A (en) Oral pharmaceutical preparation containing erythromycin base
JPH07173057A (ja) イブプロフェン含有粒剤
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
GB2258613A (en) Pharmaceutical diltiazem spheroid formulation
US20100172986A1 (en) Controlled release composition and preparation thereof
KR20020031419A (ko) 트라마돌 사카리네이트를 함유하는 지효성 투여형

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20150622